Cargando…
Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma
Cyclooxygenase-2 (COX-2), 5-Lipoxygenase (5-LOX), and epidermal growth factor receptor (EGRF) are over-expressed in human pancreatic ductal adenocarcinoma (PDAC). Using next-generation sequencing (NGS) analysis, we show significant increase in COX-2, 5-LOX, and EGFR expression during PDAC progressio...
Autores principales: | Rao, Chinthalapally V., Janakiram, Naveena B., Madka, Venkateshwar, Devarkonda, Vishal, Brewer, Misty, Biddick, Laura, Lightfoot, Stan, Steele, Vernon E., Mohammed, Altaf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741766/ https://www.ncbi.nlm.nih.gov/pubmed/26429877 |
Ejemplares similares
-
Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer
por: Janakiram, Naveena B., et al.
Publicado: (2016) -
Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer
por: Mohammed, Altaf, et al.
Publicado: (2017) -
Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression
por: Mohammed, Altaf, et al.
Publicado: (2015) -
Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats
por: Madka, Venkateshwar, et al.
Publicado: (2023) -
Early and delayed intervention with Rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice
por: PATLOLLA, JAGAN M.R., et al.
Publicado: (2015)